Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06544915 · ClinicalTrials.gov registry record · NA
Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial
A NA study of Blood Pressure, Body Composition, Immune Function, sponsored by Skidmore College.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06544915: Recruiting NA study of Blood Pressure, Body Composition, Immune Function, sponsored by Skidmore College.
NCT06544915 is a NA study of Blood Pressure, Body Composition, Immune Function that is actively recruiting participants, run by Skidmore College. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06544915, a NA study of Blood Pressure, Body Composition, Immune Function, is actively recruiting participants, sponsored by Skidmore College.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Accordingly, the purpose of this study is to evaluate the efficacy of 1) supplementation with Synbiotic (Plexus® Triplex), 2) commercially-available Probiotic, or 3) placebo control over 30 days on the gut microbiome, cardiometabolic health, body weight and body composition in healthy individuals.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Synbiotic, Probiotic, Placebo
Study Locations (1)
New York
- Skidmore College - Saratoga Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-07-23 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What NCT06544915 shows while recruiting
NCT06544915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Blood Pressure, Body Composition, Immune Function appearing as the primary indexed condition, and to 1 intervention - of which Synbiotic, Probiotic, Placebo is the first listed.
NCT06544915 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06544915 about?
NCT06544915 is a clinical study titled "Evaluating the Effects of a Synbiotic Versus Probiotic or Placebo on Gut Microbiota and Cardiometabolic Health: A Randomized Double-Blind Placebo Controlled Trial". Accordingly, the purpose of this study is to evaluate the efficacy of 1) supplementation with Synbiotic (Plexus® Triplex), 2) commercially-available Probiotic, or 3) placebo control over 30 days on the gut microbiome, cardiometabolic health, body weight and body composition in healthy individuals.
What is the current status of trial NCT06544915?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-07-23. Estimated completion is 2025-01-01.
What conditions does trial NCT06544915 study?
This clinical trial studies the following conditions: Blood Pressure, Body Composition, Immune Function.
What interventions are being tested in trial NCT06544915?
The interventions under investigation include: Synbiotic, Probiotic, Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06544915?
This trial is sponsored by Skidmore College, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06544915 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06544915's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI